Drug intelligence / Profile preview

ALK-depot SQ mites

Development stage
Phase 3
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

ALK-depot SQ mites is an allergen extract-based immunotherapy product developed by ALK-Abelló for the treatment of immune system diseases, particularly allergic conditions related to house dust mite sensitization. It is administered as a subcutaneous injection (SCIT) and functions as an immunomodulator, aiming to induce immune tolerance to house dust mite allergens. The drug has been studied in clinical trials for atopic dermatitis with proven IgE-mediated sensitization to house dust mites, showing improvements in skin and other organ manifestations associated with allergy[1][2][4]. Its mechanism involves modulating the immune response against specific allergens.

Brand names
ALK-depot SQ mites

Beyond the preview

Go deeper on ALK-depot SQ mites.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALK-depot SQ mites.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call